Progress and current challenges in treatment of acute myocardial infarction in China / 天津医药

ABSTRACT

With high incidence, high mortality, high disability and high medical cost, acute myocardial infarction (AMI), the most acute events of coronary heart disease (or the acute exacerbation of chronic coronary disease), becomes the priority in preventing and treating cardiovascular diseases and the vital point of reducing cardiovascular mortality. In recent years, with the continuous improvement of AMI treatment strategy and the application of new treatment methods, based on the recent large-scale clinical trials, the guideline of treating AMI are constantly updated at home and abroad to better guide clinical work. In this paper, we share the advanced technologies and concepts in treating AMI, and look forward to the new academic frontiers. We aim to make a brief analysis of the latest treatment guidelines and the latest research progress.